Suppression of myoclonus in SCA2 by piracetam.
De Rosa A., Striano P., Barbieri F., de Falco A., Rinaldi C., Tucci T., Striano S., Filla A., De Michele G.
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.